Authors: Hillyer L L, Ridd Z, Fenwick S, Hincks P, Paine S W
Journal: Equine veterinary journal
Summary
# Editorial Summary: Cobalt-to-Vitamin B12 Ratios as a Doping Control Strategy in Horses Cobalt is essential for vitamin B12 synthesis, yet excessive supplementation enhances performance and poses welfare risks—creating a regulatory challenge since legitimate B12 products necessarily contain cobalt. Hillyer and colleagues administered either a standard B12/cobalt supplement or high-dose cobalt chloride to six Thoroughbreds, then tracked plasma and urine cobalt and B12 concentrations over weeks using immunoassay and ICP-MS analysis. The cobalt-to-B12 ratio proved markedly different between the two scenarios: legitimate supplementation produced a transient plasma ratio peaking around 3 before normalising within days, whereas high-dose doping generated plasma ratios exceeding 10 (remaining above 1 for 7 days, and up to 28 days in extended sampling), with urine ratios staying above 10 for approximately 18 days despite absolute cobalt dropping below current international thresholds within 96 hours. These findings suggest that incorporating cobalt-to-B12 ratio thresholds alongside existing absolute cobalt limits could distinguish genuine supplementation from abuse whilst preserving legitimate equine healthcare, though the authors note their single product evaluation and small, untrained sample population warrant validation across diverse supplementation protocols and racing populations.
Read the full abstract on PubMed
Practical Takeaways
- •Racing regulators may use cobalt:B12 ratios alongside absolute thresholds to distinguish therapeutic supplementation from performance-enhancing doping in competition horses
- •A urine ratio above 10 for more than 7 days indicates potential cobalt abuse rather than legitimate B12 supplementation, even when absolute cobalt levels fall below current thresholds
- •Understand that standard cobalt thresholds alone may not detect prolonged high-dose cobalt administration; ratio-based testing provides additional detection window
Key Findings
- •Vitamin B12/cobalt supplement administration produced plasma cobalt:B12 ratios of approximately 3 that rapidly declined below 1 within one week
- •High-dose cobalt chloride (100 mg) produced plasma ratios exceeding 10 that remained above 1 for 7 days (28 days in extended sampling)
- •Urine cobalt:B12 ratio exceeded 10 for 7 days after high-dose cobalt administration despite absolute cobalt dropping below 100 ng/mL threshold after 96 hours
- •Cobalt:vitamin B12 ratios in plasma and urine can differentiate legitimate supplementation from high-dose cobalt doping